Decision outcomes following referral to a tertiary severe asthma service for MAb therapy.
A. Nuttall (Liverpool, United Kingdom), H. Joplin (Liverpool, United Kingdom), C. Lowe (Liverpool, United Kingdom), G. Jones (Liverpool, United Kingdom), S. Zaidi (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom), L. Chishimba (Liverpool, United Kingdom)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2396
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nuttall (Liverpool, United Kingdom), H. Joplin (Liverpool, United Kingdom), C. Lowe (Liverpool, United Kingdom), G. Jones (Liverpool, United Kingdom), S. Zaidi (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom), L. Chishimba (Liverpool, United Kingdom). Decision outcomes following referral to a tertiary severe asthma service for MAb therapy.. 2396
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|